Abstract
The intention of this chapter is to review existing experimental data on combinations of cytotoxic drugs and hyperthermia. The focus will be on those drugs which are the most likely candidates for potentiation by hyperthermia, and attention will be drawn to findings which may form a basis for the design of clinical studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adams GE (1978) Hypoxic cell sensitizers for radiotherapy. Int J Radiat Oncol Biol Phys 4: 135–141
Adams GE, Stratford IJ, Wallace RG, Wardman P, Watts ME (1980) Toxicity of nitro compounds toward hypoxic mammalian cells. J Natl Cancer Inst 64: 555–560
Alberts DS, Peng YM, Chen GHS, Moon TE, Cetas TC, Hoescheie JD (1980) Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J Natl Cancer Inst 65: 445–461
Amano T, Kumini K, Nakashima K, Uchibayashi T, Hisazumi H (1990) A combined therapy of hyperthermia and tumor necrosis factor for nude mice bearing KK-47 bladder cancer. J Urol 144: 370–374
Ânggard E (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343: 1199–1206
Anjum A, Fleischmann WR Jr (1992) Effect of hyperthermia on the antitumor actions of interferons. J Biol Regul Homeost Agents 6: 75–86
Ausmus PL, Wilke AV, Frazier DL (1992) Effects of hyperthermia on blood flow and cis-diamminedichloroplatinum(II) pharmacokinetics in murine mammary adenocarcinomas. Cancer Res 52: 4965–4968
Barlogie B, Corry PM, Drewinco B (1980) In vitro thermochemotherapy of human colon cancer cells with cisdichlorodiammineplatinum(II) and mitomycin C. Cancer Res 40: 1165–1168
Barry MA, Behnke CA, Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353–2362
Bates DA, MacKillop WJ (1989) The effect of hyperthermia on the uptake and cytotoxicity of melphalan in Chinese hamster ovary cells. Int J Radiat Oncol Biol Phys 16: 187–191
Bates DA, MacKillop WJ (1990) The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro. Br J Cancer 62: 183–188
Ben-Hur E, Elkind MM (1974) Thermal sensitization of Chinese hamster cells to methyl methanesulfonate: relation of DNA damage and repair to survival response. Cancer Biochem Biophys 1: 23–32
Bertrand R, Kerrigan D, Sarang M, Pommier Y (1991) Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells. Biochem Pharmacol 42: 7–85
Bleehen NM, Walton MI, Workman P (1988) Interactions of hyperthermia with hypoxic cell sensitizers. Recent Results Cancer Res 109: 136–148
Bronk BV, Wilkins RJ, Regan JD (1973) Thermal enhancement of DNA damage by an alkylating agent in human cells. Biochem Biophys Res Commun 52: 1064–1071
Ciocca DR, Fuqua SA, Lock Lim S, Toft DO, Welch WJ, McGuire WL (1992) Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52: 3648–3654
Cohen JD, Robins HI, Schmitt CL (1989) Tumoricidal interactions of hyperthermia with carboplatin and etopocide. Cancer Letters 44: 205–210
Cohen JD, Robins HI (1987) Hyperthermic enhancement of cis-diammine-1, 1-cyclubutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro. Cancer Res 47: 4335–4337
Cohen JD, Robins HI (1990) Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells. Int J Hyperthermia 6: 1013–1017
Cohen JD, Robins HI, Schmitt CL (1989) Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide. Cancer Lett 44: 205–210
Dahl O (1982) Interaction of hyperthermia and doxorubicin on a malignant, neurogenic rat cell line (BT4C) in culture. Natl Cancer Inst Monogr 61: 251–253
Dahl O (1983) Hyperthermic potentiation of doxorubicin and 4’-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats. Int J Radiat Oncol Biol Phys 9: 203–207
Dahl O (1994) Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E (eds) Hyperthermia and Oncology, vol 4, VSP, Utrecht, pp 9–28
Dahl O, Mella O (1982) Enhancement effect of combined hyperthermia and chemotherapy (bleomycin, BCNU) in a neurogenic rat tumour (BT4A) in vivo. Anticancer Res 2: 359–364
Dahl O, Mella O (1983) Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumour (BT4A) in vivo. Cancer 52: 983–987
Dahl O, Mella O (1990) Hyperthermia and chemotherapeutic agents. In: Field SB, Hand JW (eds) An introduction to the practical aspects of clinical hyperthermia. Taylor & Francis, London, pp 108–142
Da Silva VF, Feely M, Raaphorst GP (1991) Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells. J Neurooncol 11: 37–41
de L Davies C, Basham TY, Anderson RL, Hahn GM (1990) Changes in the expression of idiotype antigen on murine B-cell lymphoma after hyperthermia alone and in combination with interferon and tumour necrosis factor. Int J Cancer 45: 500–507
DeGraeff A, Slebos RJ, Rodenhius S (1988) Resistance to cisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemother Pharmacol 22: 325–332
De Neve W, Fortan L, Van Den Berghe D, Storme G (1991) Modulation of cis-and carboplatin cytotoxicity by whole-body hyperthermia: absence of a differential and increased DNA-protein cross-link formation (meeting abstract). Strahlenther Onkol 167: 352
Dickson JA, Suzangar M (1974) In vitro — in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees). Cancer Res 34: 1263–1274
Dogramatzis D, Nishikawa K, Newman RA (1991) Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro. Anticancer Res 11: 359–364
Donaldson SS, Gordon LF, Hahn GM (1978) Protective effect of hyperthermia against the cytotoxicity of actinomycin D on Chinese hamster cells. Cancer Treat Rep 62: 1489–1495
Douple EB, Strohben JW, de Sieyes DC, Alborough DP, Trembley BS (1982) Therapeutic potentiation of cisdichlorodiammineplatinum(II) and radiation by interstitial microwave hyperthermia in a mouse tumour. Natl Cancer Inst Monogr 61: 259–262
Dynlacht JR, Wong RS, Albright N, Dewey WC (1994) Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavage complexes. Cancer Res 54: 4129–4137
Fisher GA, Hahn GM (1982) Enhancement of cisplatinum(II) diamminedichloride cytotoxicity by hyperthermia. Natl Cancer Inst Monogr 61: 255–257
Fleischmann WR Jr, Fleischmann CM, Gindhart TD (1986) Effect of hyperthermia on the antiproliferative activities of murine α, ß-, and γ-interferon: Differential enhancement of murine γ-interferon. Cancer Res 46: 8–13
Fleischmann WR Jr, Fleischmann CM, Gindhart TD (1986a) Effect of hyperthermia on combination interferon treatment: Enhancement of the antiproliferative activity against murine B-16 melanoma. Cancer Res 46: 1722–1726
Fujimoto S, Kobayashi K, Takahashi M, Konno C, Kokubun M, Ohta M, Shrestha RD, Kiuchi S (1992) Effects on tumour microsirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia. Br J Cancer 65: 33–36
Fujiwara K, Kohno I, Miyao J, Sekiba K (1984) The effect of heat on cell proliferation and the uptake of anticancer drugs into tumour. In: Overgaard J (ed) Hyperthermic oncology 1984, vol 1. Taylor & Francis, London, pp 405–408
Giovanella BC, Lohman WA, Heidelberger C (1970) Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells. Cancer Res 30: 1623–1631
Goss P, Parsons PG (1977) The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines. Cancer Res 37: 152–156
Hahn GM (1978) Interactions of drugs and hyperthermia in vitro and in vivo. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban & Schwarzenberg, Munich, pp 72–79
Hahn GM (1979) Potential for therapy of drugs and hyperthermia. Cancer Res 39: 2264–2268
Hahn GM, Shiu EC (1983) Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res 43: 5789–5791
Hahn GM, Strande DP (1976) Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 57: 1063–1067
Hahn GM, Braun J, Har-Kedar I (1975) Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72: 937–940
Har-Kedar I (1975) Effect of hyperthermia and chemotherapy in EMT6 cells. In: Wizenberg MJ, Robinson JE (eds) Proceedings International Symposium on Cancer Therapy by Hyperthermia and Radiation, ACR Washington DC, pp 91–93
Hassanzadeh M, Chapman IV (1982) Thermal enhancement of bleomycin-induced growth delay in a squamous carcinoma of CBA/Ht mouse. Eur J Clin Oncol 18: 795–797
Hazan G, Ben-Hur E, Yerushalmi A (1981) Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionation. Eur J Cancer 6: 681–684
Herman TS (1983a) Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone. Cancer Treat Rep 67: 1019–1022
Herman TS (1983b) Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-l-nitrosourea cytotoxicity in vitro. Cancer Res 43: 365–369
Herman TS, Teicher BA (1988) Sequencing of trimodality therapy (cis-diamminedichloroplatinum(II)/hyperthermia/radiation) as determined by tumor growth delay and tumor cell survival in the FSallc fibrosarcoma. Cancer Res 48: 2693–2697
Herman TS, Teicher BA, Chan V, Collins LS, Abrams MJ (1989) Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 16: 443–449
Herman TS, Teicher BA, Pfeffer MR, Khandekar VS (1990a) Interaction with hyperthermia of platinum complexes of triaminotriphenylmethane dyes. Int J Hyperthermia 6: 629–639
Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Alvarez-Sotomayor E (1990b) Interaction of platinum complexes of thiazin and xanthine dyes with hyperthermia. Cancer Chemother Pharmacol 26: 127–134
Herman TS, Teicher BA, Holden SA (1990c) Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C. Int J Radiat Oncol Biol Phys 18: 375–382
Herman TS, Teicher BA, Holden SA (1991) Addition of mitomycin C to cis-diamminedichloroplatinum(II)/ hyperthermia/radiation therapy in the FSallC fibrosarcoma. Int J Hyperthermia 7: 893–903
Hofer KG, MacKinnon AR, Schubert AL, Lehr JE, Grimmett EV (1981) Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat. Radiology 141: 801–809
Honess DJ, Workman P, Morgan JE, Bleehen NM (1980) Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anesthetized mouse. Br J Cancer 41: 529–540
Honess DJ, Bleehan NM (1982a) Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Br J Cancer 46: 236–248
Honess DJ, Bleehen NM (1982b) Effects of the combination of hyperthermia and cytotoxic agents on the skin of the mouse foot. In: Arcangeli G, Mauro F (eds) Proceedings of the first meeting of the European Group of Hyperthermia in Radiation Oncology. Masson, Milan, pp 151–155
Honess DJ, Bleehen NM (1985a) Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours. Int J Hyperthermia 1: 57–68
Honess DJ, Bleehen NM (1985b) Thermochemotherapy with cisplatinum CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only. Br J Radiol 58: 63–72
Hou D-Y, Maruyama Y (1990) Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex. J Surg Oncol 44: 5–9
Ilzumi T, Yazaki T, Waku M, Soma G-I (1989) Immuno-chemotherapy for murine bladder tumour with a human recombinant tumour necrosis factor (rTNF-S), VP-16 and hyperthermia. J Urol 142: 386–389
Johnson HA, Pavelec M (1973) Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst 50: 903–908
Joiner MC, Steel GC, Stephens IC (1982) Response of two mouse tumours to hyperthermia with CCNU or melphalan. Br J Cancer 45: 17–26
Juvekar AS, Chitnis MP (1991) Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxanthrone with hyperthermia (42°C). Neoplasma 38: 207–211
Kano E, Furukawa-Furuya M, Kajimoto-Kinoshita KNT, Picha P, Sugimoto K, Ohtsubo T, Tsuji K, Tsubouchi S, Kondo T (1988) Sensitivities of bleomycin-resistant variant cells enhanced by 40°C hyperthermia in vitro. Int J Hyperthermia 4: 547–553
Kappel M, Diamant M, Hansen MB, Klokker M, Pedersen BK (1991) Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma. Immunology 73: 304–308
Kallinowski F, Schaefer G, Tyler G, Vaupel P (1989) In vivo targets of recombinant human tumour necrosis factor-a: blood flow, oxygen consumption and growth of isotransplanted rat tumours. Br J Cancer 60: 555–560
Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870–5878
Kim JH, Kim SH, Alifieri A, Young CW, Silvestrini B (1984) Lonidamine: A hyperthermic sensitizer of HeLa cels in culture and of the Math-A tumor in vivo. Oncology 41: Suppl 1, pp 30–35
Kim YD, Lees DE, Lake CR, Wang-Peng J, Schuette W, Smith R, Bull J (1979) Hyperthermia potentiates doxorubicin-related cardiotoxic effects. JAMA 241: 1816–1817
Kitamura K, Kuwano H, Matsuda H, Toh Y, Masuda H, Sugimachi K (1992) Synergistic effects of intratumor administration of cis-diamminedichloroplatinum(II) combined with local hyperthermia in melanoma bearing mice. J Surg Oncol 51: 188–194
Klostergaard J, Leroux E, Siddik ZH, Khodadadian M, Tomasovic SP (1992) Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy. Cancer Res 52: 5271–5277
Kuroki M, Tanaka R, Hondo H (1987) Antitumour effect of interferon combined with hyperthermia against experimental brain tumour. Int J Hyperther 3: 527–534
Kukla L, Mc Guire WP (1982) Heat-induced recall of bleomycin skin changes. Cancer 50: 2283–2284
Laskowitz DT, Elion GB, Dewhirst MW, Griffith OW, Savina PM, Blum MR, Prescott DM, Bigner DD, Friedman HS (1992) Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft. Radiat Res 129: 218–223
Lee YJ, Hou Z, Curetty L, Cho JH, Corry PM (1993) Synergistic effect of cytokine and hyperthermia on cytotoxicity in HT-29 cells are not mediated by alterations of induced protein levels. J Cell Physiol 155: 27–35
Lejeune FJ, Li’enard D, Leyvraz S, Mirimanoff RO (1993) Regional therapy of melanoma. Eur J Cancer 29A: 606–612
Lindegaard JC, Radacic M, Khalil AA, Horsman MR, Overgaard J (1992) Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Acta Oncol 31: 347–351
Los G, Sminia P, Wondergem J, Mutsaers PHA, Haveman J, ten Bokkel Huinink D, Smals O, Gonzalez-Gonzalez D, McVie JG (1991) Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 27: 472–477
Ma F, Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M (1985) Response of mammary tumours of C3H/He mice to hyperthermia and bleomycin in vivo. Radiat Med 3: 230–233
Magin RL, Sisik BI, Cysyk RL (1979) Enhancement of bleomycin activity against Lewis lung tumors in mice by local hyperthermia. Cancer Res 39: 3792–3795
Magin RL, Cysyk RL, Litterst CL (1980) Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy. Cancer Treat Rep 64: 203–210
Majima H, Kashiwado K, Egawa S, Suzuki N, Urano M (1992) Interaction between the kinetics of thermotolerance and effect of cis-diamminedichloroplatinum(II) or bleomycin given at 37 or 43°C. Int J Hyperthermia 8: 431–442
Mansouri A, Henle KJ, Benson AM, Moss AJ, Nagle WA (1989) Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Res 49: 2674–2678
Marmor JB, Kozak D, Hahn GM (1979) Effects of systemically administered bleomycin or adriamycin with local hyperthermia. Cancer Treat Rep 63: 1279–1290
Mella O (1985) Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours. Int J Hyperthermia 1: 171–183
Mella O (1990) Fractionated hyperthermia in vivo: thermotolerance, sensitivity to BCNU and thermochemotherapy in the BT4An rat glioma. Int J Hyperthermia 6: 253–260
Mella O, Dahl O (1985) Timing of combined hyperthermia and l,3-bis(2-chloroethyl)-l-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours. Anticancer Res 5: 259–264
Mella O, Eriksen R, Dahl O, Laerum OD (1987) Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. Eur J Cancer Clin Oncol 23: 365–373
Meyn RE, Corry PM, Fletcher SE, Demetriades M (1980) Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 40: 1136–1139
Mircheva J, Smith PJ, Bleehen NM (1986) Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells. I. In vitro cytotoxicity. Br J Cancer 53: 99–103
Mizuno S, Amagai M, Ishida A (1980) Synergistic cell killing by antitumor agents and hyperthermia in cultured cells. Gann 71: 471–478
Monge OR, Rofstad EK (1989) Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: thermotolerant tumours. Int J Hyperthermia 5: 579–587
Monge OR, Rofstad EK (1991) Fractionated thermochemotherapy in vivo of a C3H mouse mammary carcinoma. Radiother Oncol 21: 171–178
Monge OR, Rofstad EK, Kaalhus O (1988) Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: single fraction heat and drug treatment. Eur J Cancer Clin Oncol 24: 1661–1669
Morgan JE, Bleehen NM (1982) A comparison of the interaction between hyperthermia and bleomycin on the EMT6 tumour as a monolayer or spheroids in vitro and in vivo. In: Arcangeli G, Mauro F (eds) Proceedings of the first meeting of the European Group of Hyperthermia in radiation oncology. Masson, Milan, pp 165–170
Morgan JE, Honess DJ, Bleehen NM (1979) The interaction of thermal tolerance with drug cytotoxicity in vitro. Brit J Cancer 39: 422–428
Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A (1991). Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging. Bone Marrow Transplant 8: 301–305
Muckle DS, Dickson JA (1973) Hyperthermia (42°C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit. Br J Cancer 27: 307–315
Mulcahy RT, Gipp JJ, Tanner MA (1988) Sensitization of nitrosourea-resistant Mer(+) human tumor cells to N-(2-chloroethyl)-N’-cyclohexyl-N-nitrosourea by mild (41°C) hyperthermia. Cancer Res 48: 1086–1090
Nakajima K, Hisazumi H (1987) Enhanced radioinduced cytotoxicity of cultured human bladder cells using 43°C hyperthermia and anticancer drugs. Urol Res 15: 255–260
Nakayama J, Toyofuku K, Urabe A, Taniguchi S, Hori Y (1993) A combined therapeutic modality with hyperthermia and locally administered rIFN-β inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates. J Deratol Sci 6: 240–246
Neilan BA, Henle KJ (1989) In vivo response of murine RIF tumors to thermochemotherapy. J Med 20: 107–112
Neumann HA, Herrmann DB, Fiebig HH, Engelhardt R (1989) Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5°C hyperthermia in vitro. Eur J Cancer Clin Oncol 25: 99–104
Newman RA, Dogramatzis D, Benvenuto JA, Trevino M, Stephens LC, Wondergem J, Strebel R, Baba H, Bull JM (1992) Effect of whole-body hyperthermia on pharmacokinetics and tissue distribution of doxorubicin. Int J Hyperthermia 8: 79–85
O’Donnel JF, McKoy WS, Makuch RW, Bull JM (1979) Increased in vitro toxicity to mouse bone marrow with l,3-bis(2-chloroethyl)-l-nitrosourea and hyperthermia. Cancer Res 39: 2547–2549
Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF, Withrow SJ (1991) Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 198: 1618–1621
Ohno S, Strebel FR, Stephens C, Siddik ZH, Makino M, Klostergaard J, Tomasovic SP, Kokhar AR, Bull JM (1992) Increased therapeutic efficacy induced by tumor necrosis factor a combined with platinum complexes and whole-body hyperthermia in rats. Cancer Res 52: 4096–4101
Onishi T, Machida T, Mori Y, Ilzuka N, Masuda F, Mochizuki S, Tsukamoto H, Harada N (1989) Hyperthermia with simultaneous administration of interferon using established human renal carcinoma heterotransplanted in nude mice. Br J Urol 63: 227–232
Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, Khokhar AR, Bull JM (1991) Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 51: 2994–3000
Ohtsubo T, Chang SW, Tsuji K, Picha P, Saito H, Kano E (1990) Effects of cis-diamminedichloroplatinum (CDDP) and cis-diammine(l, 1-cyclobutanedicar-boxylate)platinum (CBDCA) on thermotolerance development and thermosensitivity of the thermo-tolerant cells. Int J Hyperthermia 6: 1031–1039
Osieka R, Magin RL, Atkinson ER (1978) The effect of hyperthermia on human colon cancer xenografts in nude mice. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban & Schwarzenberg, Munich, pp 287–290
Overgaard J (1976) Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res 36: 3077–3081
Overgaard J (1980) Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. Br J Cancer 41: 10–21
Overgaard J (1989) The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 16: 535–549
Overgaard J, Sand Hansen H, Lindel0v B, Overgaard M, J0rgensen K, Rasmussen B, Berthelsen A (1991) Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother Oncol 20: 143–149
Pfeffer MR, Teicher BA, Holden SA, Al-Achi A, Herman TS (1990) The interaction of cisplatin plus etoposide with radiation ± hyperthermia. Int J Radiat Oncol Biol Phys 19: 1439–1447
Pilepich MV, Jones KG, Emami BN, Perez CA, Fields JN, Myerson RJ (1989) Interaction of bleomycin and hyperthermia–results of a clinical pilot study. Int J Radiat Oncol Biol Phys 16: 211–213
Raaphorst GP, Feeley MM, Danjoux CE, Martin L, Maroun J, DeSantis AJ (1991) The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines. Int J Radiat Oncol Biol Phys 20: 509–515
Raaphorst GP, Feeley MM, Martin L, Danjoux CE, Maroun J, DeSantis AJ (1991a) Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cells. Int J Hyperther 7: 763–722
Rabbani B, Sondhaus CA, Swingle KF (1978) Cellular response to hyperthermia and bleomycin: effect of time sequencing and possible mechanisms. Proceedings of the international symposium on cancer therapy by hyperthermia and radiation. American College of Radiology, Washington DC, 1975
Rice GC, Hahn GM (1987) Modulation of adriamycin transport by hyperthermia as measured by fluorescenceactivated cell sorting. Cancer Chemother Pharmacol 20: 183–187
Roizin-Towle L, Hall EJ, Capuano L (1982) Interaction of hyperthermia and cytotoxic agents. Natl Cancer Inst Monogr: 149–151
Rose WC, Veras GH, Laster WR Jr, Schabel FM Jr (1979) Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. Cancer Treat Rep 63: 1311–1325
Sakaguchi Y, Makino M, Kaneko T, Stephens LC, Strebel FR, Danhauser LL, Jenkins GN, Bull JMC (1994) Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 54: 2223–2227
Schem BC, Dahl O (1991) Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4AN rat glioma. J Neurooncol 10: 247–252
Schem BC, Mella O, Dahl O (1989) Potentiation of combined BCNU and hyperthermia by pH reduction in vitro and hypertonic glucose in vivo in the BT-4 rat glioma. Int J Hyperthermia 5: 707–715
Schem BC, Kronen-Krossnes B, Mella O, Dahl O (1991) Intra-arterial ACNU and local brain hyperthermia in rat BT4AN gliomas (meeting abstract). Strahlenther Onkol 167: 356
Schem BC, Mella O, Dahl O (1992) Thermochemotherapy with cisplatin or carboplatin in the BT-4 rat glioma in vitro and in vivo. Int J Radiat Oncol Biol Phys 23: 109–114
Senapati N, Houchens D, Ovejera A, Beard R, Nines R (1982) Ultrasonic hyperthermia and drugs as therapy for human tumor xenografts. Cancer Treat Rep 66: 1635–1639
Shiu MH, Cahan A, Fogh J, Fortner JG (1983) Sensitivity of xenografts of human pancreatic adenocarcinomas in nude mice to heat and heat combined with chemotherapy. Cancer Res 43: 4014–4018
Someya T, Nogita T, Yamada K, Tsuchida T, Watanabe R, Otsuka F (1990) Antiproliferative effect of hyperthermia and ACNU on cultured human malignant melanoma cells. J Dermatol 17: 303–306
Srinivasan JM, Fajarda L, Hahn GM (1990) Mechanism of antitumor activity of tumor necrosis factor a with hyperthermia in a tumor necrosis factor α-resistant tumor. J Natl Cancer Inst 82: 1904–1910
Sutton CH (1971) Tumour hyperthermia in the treatment of malignant gliomas of the brain Trans Am Neurol Assoc96: 195–199
Suzuki K (1967) Application of heat to cancer chemotherapy — experimental studies. Nagoya J Med Sci 30: 1–21
Teicher BA, Holden SA, Khandakar V, Herman TS (1993) Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/ heat/radiation] in a murine tumor. J Cancer Res Clin Oncol 119: 645–651
Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC (1981) Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 41: 1096–1099
Teicher BA, Herman TS, Holden SA (1988) Combined modality therapy with bleomycin, hyperthermia, and radiation. Cancer Res 48: 6291–6297
Teicher BA, Herman TS, Pfeffer MR, Alvarez-Sotomayor E, Khandekar VS (1989) Interaction of PtCl-4(Fast Black)-2 with hyperthermia. Cancer Res 49: 6208–6213
Theon AP, Madewell BR, Moore AS, Stephens C, Krag DN (1991) Localized thermocisplatin therapy: a pilot study in spontaneous canine and feline tumours. Int J Hyperthermia 7: 881–892
Thuning CA, Bakir NA, Warren J (1980) Synergistic effect of combined hyperthermia and a nitrosourea in treatment of a murine ependymoblastoma. Cancer Res 40: 2726–2729
Tomasovic SP, Barta M, Klostergaard (1992) Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. Int J Hyperther 5: 625–639
Tomasovic SP, Vasey TA, Story MD, Stephens LC, Klostergaard J (1994) Cytotoxic manifestations of the interaction between hyperthermia and TNF: DNA fragmentation. Int J Hyperther 10: 247–262
Twentyman PR, Morgan JE, Donaldson J (1978) Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor. Cancer Treat Rep 62: 439–443
Uckun FM, Mitchell JB, Obuz V, Chandan Langlie M, Min WS, Haissig S, Song CW (1992) Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multidrug resistance (MDR). Int J Radiat Oncol Biol Phys 23: 115–125
Umeno H, Watanabe N, Yamauchi N, Tsuji N, Okamoto T, Niitsu Y (1994) Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor. Jpn J Cancer Res 85: 325–330
Urano M, Kahn J (1989) The effect of bleomycin administered in combination with hyperthermia on a C3H mouse fibrosarcoma. Int J Hyperthermia 5: 377–382
Urano M, Kahn J, Kenton LA (1988a) Effect of bleomycin on murine tumor cells at elevated temperatures and two different pH values. Cancer Res 48: 615–619
Urano M, Kahn J, Kenton LA (1988b) Thermochemo-therapy-induced resistance to cyclophosphamide Br J Cancer 57: 295–297
Urano M, Kahn J, Kenton LA (1990) The effect of cisdiamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 6: 563–570
Urano M, Majima H, Miller R, Kahn J (1991) Cytotoxic effect of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumour response. Int J Hyperthermia 7: 499–510
Van der Linden PWG, Sapareto SA, Corbett TH, Valeriote FA (1984) Adriamycin and heat treatments in vitro and in vivo. In: Overgaard J (ed) Hyperthermic oncology, 1984, vol 1. Taylor & Francis, London, pp 449–452
Vicente V, Gomez M, Ochotorena MM, Cremades A, Canteras M (1990) Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice. Pigment Cell Res 3: 1–7
Von Szczepanski L, Trott KR (1981) The combined effect of bleomycin and hyperthermia on the adenocarcinoma 284 of the C3H mouse. Eur J Cancer Clin Oncol 17: 997–1000
Voth B, Sauer H, Willmans W (1988) Thermostability of cytostatic drugs in vitro and thermosensitivity of cultured human lymphoblasts against cytostatic drugs. Recent Results Cancer Res 107: 170–176
Wallner KE, DeGregorio MW, Li GC (1986) Hyperthermic potentiation of cis-diamminedichloroplatinum-(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242–6245
Wallner KE, Banda M, Li GC (1987) Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C resistant Chinese hamster ovary cells. Cancer Res 47: 1308–1312
Walton MI, Bleehen NM, Workman P (1986) Effects of localized tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacoikinetics in mice. Br J Cancer 59: 667–673
Walton MI, Bleehen NM, Workman P (1989) Stimulation by localized hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in mice. Cancer Res 49: 2351–2355
Wang BS, Lumanglas AL, Ruszala-Mallon V, Wallace RE, Durr FE (1984) Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantrone (MX). Proc Am Assoc Cancer Res 25: 341
Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I (1988). Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res 48: 650–653
Wiedemann G, Roszinski S, Biersack A, Weiss C, Wagner T (1992a) Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 118: 129–135
Wiedemann G, Mella O, Roszinski S, Weiss C, Wagner T (1992b) Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. Int J Radiat Oncol Biol Phys 24: 669–673
Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens LC, Bull JMC (1988) Effect of cisdiamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res 48: 440–446
Wondergem J, Stephens LC, Strebel FR, Baba H, Ohno S, Siddik ZH, Newman RA, Bull JM (1991) Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Res 51: 3559–3567
Wong K-H (1994) Enhancement of radiosensitization and chemosensitization of nitroimidazoles by local hyperthermia. In: Urano M, Douple E (eds) Hyperthermia and Oncology, Vol 4. Chemopotentiation by hyperthermia. VSP, Utrecht, pp 285–319
Xu MJ, Alberts DS (1988) Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemother Pharmacol 21: 191–196
Yamada K, Someya T, Shimada S, Ohara K, Kukita A (1984) Thermochemotherapy for malignant melanoma: combination therapy of ACNU and hyperthermia in mice. J Invest Dermatol 82: 180–184
Yamane T, Koga S, Maeta M, Hamazone R, Karino T, Oda M (1984) Effects of in vitro hyperthermia on concentration of adriamycin in Ehrlich ascites cells. In: Overgaard J (ed) Hyperthermic Oncology 1984, Vol 1. Taylor & Francis, London, pp 409–476
Yatvin MB, Cramp WA (1993) Role of cellular membranes in hyperthermia: some observations and theories reviewed. Int J Hyperthermia 9: 165–185
Yerushalmi A (1978) Combined treatment of a solid tumour by local hyperthermia and actinomycin D. Br J Cancer 37: 827–832
Yerushalmi A, Hazan G (1979) Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results. Isr J Med Sci 15: 462–463
Zimber A, Lurie H, Hazan G, Perk K (1986) Enhancement of methyl-CCNU and cyclophosphamide inhibition of Lewis lung carcinoma in mice by local hyperthermia. Ann NY Acad Sci 463: 366–368
Zupi G, Badaracco G, Cavaliere R, Natali PG, Greco C (1984) Influence of sequence on hyperthermia and drug combination. In: Overgaard J (ed) Hyperthermic Oncology 1984, Vol 1. London, Taylor & Francis, pp 429–432
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dahl, O. (1995). Interaction of Heat and Drugs In Vitro and In Vivo. In: Seegenschmiedt, M.H., Fessenden, P., Vernon, C.C. (eds) Thermoradiotherapy and Thermochemotherapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57858-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-57858-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63382-9
Online ISBN: 978-3-642-57858-8
eBook Packages: Springer Book Archive